Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,451.00
+26.00 (1.07%)
Nov 25, 2025, 3:00 PM BST
Genus Market Cap
Genus has a market cap or net worth of 1.62 billion as of November 25, 2025. Its market cap has increased by 36.47% in one year.
Market Cap
1.62B
Enterprise Value
1.84B
Revenue
672.80M
Ranking
n/a
PE Ratio
83.91
Stock Price
2,451.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.62B, an increase of 5,129.19%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 1.62B | 59.36% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | 2.72B | 32.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.08B |
| GSK plc | 71.84B |
| Haleon | 33.11B |
| Smith & Nephew | 10.65B |
| ConvaTec Group | 4.62B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 1.85B |
| Oxford Nanopore Technologies | 1.32B |